| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Chief Financial Officer
1 company
Landau Jeffrey B serves as a Chief Business Officer at CTMX. Across recent SEC filings that breaks down to 0 buys and 6 sells.
Historically, Landau Jeffrey B's trades have earned a middling insider score of 55/100 across 6 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +1.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2024 | CTMX Cytomx Therapeutics, Inc. | Chief Business Officer | Sale+OE | 4,181 | $1.23 | $5,138.87 | -3.4% | -30.4% | +58.9% | |
| Mar 19, 2024 | CTMX Cytomx Therapeutics, Inc. | Chief Business Officer | Sell | 6,562 | $2.09 | $13,685.05 | -5.6% | -37.2% | -69.3% | |
| Dec 20, 2023 | CTMX Cytomx Therapeutics, Inc. | Chief Business Officer | Sell | 4,077 | $1.38 | $5,628.30 | -4.5% | +62.7% | -17.9% | |
| Sep 22, 2023 | CTMX Cytomx Therapeutics, Inc. | Chief Business Officer | Sell | 4,119 | $1.30 | $5,355.94 | -5.1% | +10.2% | -7.0% | |
| Mar 16, 2023 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 1,477 | $1.98 | $2,923.28 | -2.1% | -19.1% | +6.7% | |
| Jul 20, 2022 | CTMX Cytomx Therapeutics, Inc. | Chief Business Officer | Sell | 4,206 | $1.42 | $5,981.77 | -12.0% | -6.6% | +18.5% |